A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 3,279 shares of ALNY stock, worth $892,609. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,279
Previous 1,945 68.59%
Holding current value
$892,609
Previous $367,000 245628.34%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$233.81 - $287.01 $311,902 - $382,871
1,334 Added 68.59%
3,279 $902 Million
Q2 2021

Aug 30, 2021

BUY
$128.63 - $176.89 $60,198 - $82,784
468 Added 31.69%
1,945 $330,000
Q1 2021

May 20, 2021

BUY
$126.83 - $175.69 $187,327 - $259,494
1,477 New
1,477 $209,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $33.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track B. Metzler Seel. Sohn & Co. Holding Ag Portfolio

Follow B. Metzler Seel. Sohn & Co. Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.